MedTrace Logo

Imaging Extrastriatal Dopamine Release in Tobacco Smokers and Nonsmokers

NCT02348385 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 49

Last updated 2023-03-02

Study results available
· View outcomes & findings →

Summary

The goal is to examine sex differences in amphetamine-induced dopamine release in tobacco smokers and nonsmokers.

Conditions

  • Nicotine Dependence

Interventions

DRUG

Amphetamine

Subjects will have 2 PET scans on the same day. Up to 3 hours before the second PET Scan, amphetamine (0.4mg/kg, orally) will be administered.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Yale University

    lead OTHER

Principal Investigators

  • Kelly Cosgrove, PhD · Yale University

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02348385 on ClinicalTrials.gov